Target intelligence / Profile preview

Kruppel-like factor 4 (KLF4) (KLF4)

Target
KLF4
Molecular classification
Transcription factor, Zinc finger protein
01

Overview

Kruppel-like factor 4 (KLF4) is a zinc-finger transcription factor that plays a critical role in regulating cell proliferation, differentiation, and apoptosis. In the context of hematopoietic stem and progenitor cells (HSPCs), KLF4 acts as a key mediator of the stress response, often operating in a disulfide-dependent signaling network that modulates the p53 pathway. This signaling axis is sensitive to the cellular redox state, where the formation or reduction of disulfide bonds in upstream regulators can influence KLF4 stability and its subsequent interaction with p53 to dictate cell fate decisions such as quiescence or programmed cell death. KLF4 is frequently dysregulated in various cancers, including leukemias, where it can function as either a tumor suppressor or an oncogene depending on the cellular context and its interaction with other proteins like p53. Therapeutic strategies targeting this pathway often aim to restore KLF4-mediated growth arrest in malignant cells, though the complexity of its redox-sensitive regulation presents both a challenge and an opportunity for selective drug development.

Other names
GKLFEZFGut-enriched Krueppel-like factorEpithelial zinc finger protein EZF
02

Mechanism of action

Induction of KLF4 expression leading to p21-mediated cell cycle arrest and apoptosis in cancer cells.

03

Biological functions

Cell cycle regulationApoptosisCell differentiationStem cell maintenanceSignal transductionDNA damage response
04

Disease associations

CancerLeukemiaInflammationCardiovascular disease
05

Safety considerations

Potential for systemic toxicity due to broad role in normal tissue homeostasisContext-dependent role as either an oncogene or tumor suppressorRisk of affecting normal hematopoietic stem cell maintenance
06

Interacting drugs

Kenpaullone

1 more in the full profile.

07

Biomarkers

KLF4 expression levelsp53 mutation statusp21 (CDKN1A) expression

Beyond the preview

Go deeper on Kruppel-like factor 4 (KLF4) (KLF4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kruppel-like factor 4 (KLF4) (KLF4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call